A novel device for assessing dark adaptation in field settings

Alain B Labrique, Amanda C Palmer, Katherine Healy, Sucheta Mehra, Theodor C Sauer, Keith P West Jr, Alfred Sommer, Alain B Labrique, Amanda C Palmer, Katherine Healy, Sucheta Mehra, Theodor C Sauer, Keith P West Jr, Alfred Sommer

Abstract

Background: Aberrant dark adaptation is common to many ocular diseases and pathophysiological conditions, including vitamin A deficiency, cardiopulmonary diseases, and hypoxia. Scotopic vision and pupillary responsiveness have typically been measured using subjective, time-consuming methods. Existing techniques are particularly challenging for use in developing country settings, where vitamin A deficiency remains a major public health problem. Our aim was design a compact, low cost, and easily operated device to assess dark adaptation in the field.

Methods: The Portable Field Dark Adaptometer (PFDA) incorporates a digital camera, a retinal bleaching flash, and a Ganzfeld light source inside a pair of light-obscuring goggles. After a ~10 min period of dark adaption, the infrared camera digitally records afferent pupillary responses to graded light stimuli (-2.9 to 0.1 log cd/m(2)). We tested this device in a variety of field settings to assess: a) ease of use and b) whether test data could clearly and accurately depict the well-known dose-response relationship between light intensity and pupil contraction. A total of 822 videos were collected. We used an open source video analysis software to measure pupil size in pixel units. Pupillary responsiveness was expressed as the percent change in pupil size from pre- to post-light exposure. Box plots, t test, and multi-level mixed effects linear regression modeling were used to characterize the relationship between light intensity and pupillary response.

Results: The PFDA was employed with only minor technical challenges in Bangladesh, Kenya, Zambia, and Peru. Our data show a clear linear increase in pupillary constriction with increasing log light intensity. Light intensity was a strong predictor of pupillary response, regardless of baseline pupil size.

Conclusions: The consistent physiological response demonstrated here supports the use of the PFDA as a reliable tool to measure dark adaptation. As a next step, PFDA measurements will be validated against biochemical indicators of vitamin A status and hypoxemia. Ultimately, this new technology may provide a novel approach for nutritional assessment, with potential clinical applications.

Figures

Fig. 1
Fig. 1
Schematic diagram of the Portable Field Dark Adaptometer (PFDA) developed to assess impaired pupillary responses to a graded series of Ganzfeld light stimuli applied within a pair of “dark-room” goggles (a,b) with an embedded microcircuit design (c) and regulated by a laptop-powered controller box (d)
Fig. 2
Fig. 2
Infrared imaging allows the visualization of an eye in complete “dark-room” conditions while also enhancing pre (a) and post-stimulus (b) pupillary measurement due to the clear differentiation of the pupil-iris boundary, irrespective of iris color
Fig. 3
Fig. 3
Comparison of the angular profile in light intensity between the VA-20 Ganzfeld source in the commercial SST-1 device, the mock-up of the dual diffuser stack in the Portable Field Dark Adaptometer, and the ideal Lambertian reflectance across an angular illumination range of -70 to +70°
Fig. 4
Fig. 4
Trend in pupillary response across nine log-incremental steps of light intensity (left to right) in Bangladesh (a), Kenya (b), Zambia (c), and Peru (d). Pupillary response is defined as the percent change in pupil diameter from pre- to post-stimulus

References

    1. Koch W. A new instrument for dark adaptation tests. Br J Ophthalmol. 1945;29(5):234–243. doi: 10.1136/bjo.29.5.234.
    1. Working Group on Night Vision. Night Vision: Current Research and Future Directions, Symposium Proceedings. Washington, D.C.: National Academies Press; 1987.
    1. Havelius U, Hansen F, Hindfelt B, Krakau T. Human ocular vasodynamic changes in light and darkness. Invest Ophthalmol Vis Sci. 1999;40(8):1850–1855.
    1. Havelius U, Bergqvist D, Falke P, Hindfelt B, Krakau T. I. Impaired dark adaptation in symptomatic carotid artery disease. Neurology. 1997;49(5):1353–1359. doi: 10.1212/WNL.49.5.1353.
    1. Lamb TD, Pugh EN., Jr Phototransduction, dark adaptation, and rhodopsin regeneration the proctor lecture. Invest Ophthalmol Vis Sci. 2006;47(12):5137–5152. doi: 10.1167/iovs.06-0849.
    1. Carr CJ, Fisher KD. A study of individual variability in dark adaptation and night vision in man. Washington, D.C: Life Sciences Division, Army Research Office; 1970.
    1. Congdon NG, West KP., Jr Physiologic indicators of vitamin A status. J Nutr. 2002;132(9 Suppl):2889S–2894S.
    1. Congdon N, Sommer A, Severns M, Humphrey J, Friedman D, Clement L, et al. Pupillary and visual thresholds in young children as an index of population vitamin A status. Am J Clin Nutr. 1995;61(5):1076–82.
    1. Dowling JE, Wald G. Vitamin A Deficiency and Night Blindness. Proc Natl Acad Sci U S A. 1958;44(7):648–661. doi: 10.1073/pnas.44.7.648.
    1. Wald G. A portable visual adaptometer. J Opt Soc Am. 1941;31:235–238. doi: 10.1364/JOSA.31.000235.
    1. Wilson WH. The Middle East Adaptometer. Br J Ophthalmol. 1946;30(11):645–657. doi: 10.1136/bjo.30.11.645.
    1. Yarbrough ME, Dann WJ. Dark adaptometer and blood vitamin A measurements in a North Carolina Nutrition Survey. J Nutr. 1941;22:597–607.
    1. Peters AY, Locke KG, Birch DG. Comparison of the Goldmann-Weekers dark adaptometer and LKC Technologies Scotopic Sensitivity tester-1. Doc Ophthalmol. 2000;101(1):1–9. doi: 10.1023/A:1002765024774.
    1. Congdon NG, Dreyfuss ML, Christian P, Navitsky RC, Sanchez AM, Wu LS, et al. Responsiveness of dark-adaptation threshold to vitamin A and beta-carotene supplementation in pregnant and lactating women in Nepal. Am J Clin Nutr. 2000;72(4):1004–9.
    1. Sanchez AM, Congdon NG, Sommer A, Rahmathullah L, Venkataswamy PG, Chandravathi PS, et al. Pupillary threshold as an index of population vitamin A status among children in India. Am J Clin Nutr. 1997;65(1):61–6.
    1. West Jr KP, Christian P, Labrique AB, Rashid M, Shamim AA, Klemm RD, et al. Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial. JAMA. 2011;305(19):1986–95.
    1. World Health Organization . Global prevalence of vitamin A deficiency in populations at risk 1995–2005. WHO Global Database on Vitamin A Deficiency. Geneva, Switzerland: World Health Organization; 2009. p. 116.
    1. Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W, Cronicas Cohort Study Group. Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open. 2012;2(1), e000610.
    1. Sommer A, West Jr KP. Vitamin A and childhood morbidity. Lancet. 1992;339(8804):1302.
    1. Kiser AK, Mladenovich D, Eshraghi F, Bourdeau D, Dagnelie G. Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease. Invest Ophthalmol Vis Sci. 2006;47(1):444–452. doi: 10.1167/iovs.04-1146.
    1. De Moura FF, Palmer AC, Finkelstein JL, Haas JD, Murray-Kolb LE, Wenger MJ, et al. Are biofortified staple food crops improving vitamin a and iron status in women and children? New evidence from efficacy trials. Adv Nutr. 2014;5(5):568–70.
    1. Abbott-Johnson WJ, Kerlin P, Abiad G, Clague AE, Cuneo RC. Dark adaptation in vitamin A-deficient adults awaiting liver transplantation: improvement with intramuscular vitamin A treatment. Br J Ophthalmol. 2011;95(4):544–548. doi: 10.1136/bjo.2009.179176.
    1. Jackson GR, Edwards JG. A short-duration dark adaptation protocol for assessment of age-related maculopathy. J Ocul Biol Dis Inform. 2008;1(1):7–11. doi: 10.1007/s12177-008-9002-6.
    1. Kalaboukhova L, Fridhammar V, Lindblom B. Relative afferent pupillary defect in glaucoma: a pupillometric study. Acta Ophthalmol Scand. 2007;85(5):519–525. doi: 10.1111/j.1755-3768.2006.00863.x.
    1. Owsley C, McGwin G, Jr, Jackson GR, Kallies K, Clark M. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology. 2007;114(9):1728–1735. doi: 10.1016/j.ophtha.2006.12.023.

Source: PubMed

3
Tilaa